Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Real-Time Updates and Analysis of Dr. Reddy's Stock Performance

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Real-Time Updates and Analysis of Dr. Reddy's Stock Performance

Analysed 19 Nov 2026·2 sources analysed·Business
Real-Time Updates and Analysis of Dr. Reddy's Stock PerformancePreviousNext

The articles provide real-time updates and detailed analysis of Dr. Reddy's Laboratories' stock performance, including last traded prices around 1381.5 INR, market capitalization near 115,000-116,000 crore INR, trading volumes between 146,000 and 185,000 shares, price-to-earnings ratios around 41.2, and earnings per share of 33.54. Coverage combines fundamental and technical indicators to inform investors, offering expert insights and recommendations to support financial decision-making as of mid-November 2026.

Sentiment
50%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 29/100.

Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 19 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 18 Nov, 05:46 am. Other outlets followed.

18 Nov, 05:46 am2 sources · 23 h19 Nov, 04:48 am
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Asian Paints Stock Updates and Financial Metrics on November 18-19, 2026
Next →
Bharti Airtel Stock Updates and Financial Performance Analysis November 2026
economictimes18 Nov, 05:46 am
Dr Reddys Share Price Live Updates: Dr. Reddys Stock Update
  • 2
    economictimes19 Nov, 04:48 am
    Dr Reddys Share Price Live Updates: Dr. Reddys Stock Details
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Dr Reddy's Laboratories LimitedDr Reddys Laboratories Limited

    Story context

    Category
    Business
    Sources analysed
    2
    Last analysed
    19 Nov 2026
    Key entities
    Reddi KingdomMarket capitalizationPrice–earnings ratioAmplitude modulation